Company intelligence / Profile preview

SML Meditree

Seoul, Seoul, South Koreamedi-tree.com ↗

Ownership: Private
Development stage: Commercial

Overview

SML Meditree is Korea’s first central laboratory service provider dedicated to supporting Asia-based clinical trials. The company offers GCLP-compliant central lab services with ISO9001/14001 certifications. It specializes in customizable analyses of clinical samples using its proprietary RVDS system for efficient trial management. The company has expanded capabilities in LC-MS/MS bioanalysis and flow cytometry, serving both domestic and multinational studies across Asia. Recent partnerships include distribution of advanced immune proteomics platforms like KREX from Sengenics in South Korea.

Modalities: Molecular diagnosticsBioanalytical testingFlow cytometry-based assays
Industry: Contract Research Organization

Partnerships

Sengenics

Beyond the preview

Go deeper on SML Meditree.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SML Meditree.

Explore the full profile